David Owens - Sep 16, 2022 Form 4 Insider Report for Nexalin Technology, Inc. (NXL)

Role
Chief Medical Officer, Director
Signature
/s/ David Owens Name: David Owens, M.D.
Stock symbol
NXL
Transactions as of
Sep 16, 2022
Transactions value $
$1,000
Form type
4
Date filed
10/5/2023, 12:08 PM
Previous filing
Sep 19, 2022
Next filing
Jun 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXL Common stock warrants Purchase $1K +2.5K $0.40 2.5K Sep 16, 2022 Common Stock 2.5K $4.15 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.